$TVTX

$56.70▲ -0.3% YTD

5 SEC 13D/G filings tracked · Last updated Oct 2, 2026

Filing History

TVTX ▼ -0.3% - Travere Therapeutics, Inc.

CP $56.70▲ -0.3%Oct 2, 2026 · ThinkSabio Blog

$TVTX Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026…

News

TVTX ▼ -0.0% - Travere Therapeutics, Inc.

CP $60.28▲ -0.0%Sep 23, 2026 · ThinkSabio Blog

$TVTX Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Meth…

SEC 13D/G

TVTX - Travere Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$60.89▲ 54.11%Aug 14, 2026 · ThinkSabio Blog

$TVTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #TVTX Travere Therapeutics, Inc. : $60.89 Sector: Healthcare | Y…

SEC 13D/G

TVTX - Travere Therapeutics, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified

$61.26▲ 55.05%Aug 12, 2026 · ThinkSabio Blog

$TVTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #TVTX Travere Therapeutics, Inc. : $61.26 Sector: Healthcare | Y…

SEC 13D/G

TVTX - Travere Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$63.47▲ 60.64%Aug 6, 2026 · ThinkSabio Blog

$TVTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #TVTX Travere Therapeutics, Inc. : $63.47 Sector: Healthcare | Y…